ERIC DOBMEIER - 28 Apr 2025 Form 3 Insider Report for Jade Biosciences, Inc. (JBIO)

Role
Director
Signature
/s/ Elizabeth Balta, as attorney-in-fact for Eric Dobmeier
Issuer symbol
JBIO
Transactions as of
28 Apr 2025
Net transactions value
$0
Form type
3
Filing time
01 May 2025, 17:39:40 UTC
Previous filing
22 Jul 2024
Next filing
01 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JBIO Stock Option (Right to Buy) 28 Apr 2025 Common Stock 93,113 $2.32 Direct F1
holding JBIO Stock Option (Right to Buy) 28 Apr 2025 Common Stock 176,771 $6.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 93,113 shares of the Issuer's common stock, one quarter of which will vest on October 23, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This option represents a right to purchase 176,771 shares of the Issuer's common stock, one quarter of which will vest on January 29, 2026, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney